Rituxem 100 mg Injection
$90.33
$78.58
Rituxem 100 mg injection is a powerful monoclonal antibody designed to target and disrupt the activity of specific immune cells, making it an essential treatment option for various autoimmune disorders and certain types of cancer, particularly non-Hodgkin's lymphoma and chronic lymphocytic leukemia. By selectively binding to the CD20 protein found on the surface of B cells, Rituxem effectively leads to the destruction of these cells, helping to reduce tumor size and manage symptoms associated with these malignancies. Patients receiving this treatment should be aware of potential side effects, including infusion reactions and an increased risk of infections, which necessitate close monitoring by healthcare professionals. It is crucial to inform your doctor about any pre-existing conditions or medications you are taking, as these factors may influence treatment outcomes. Additionally, Rituxem is not recommended for individuals with severe allergic reactions to its components. This innovative therapy has transformed the landscape of cancer treatment and offers hope for patients seeking effective management of their conditions. Always consult with a healthcare provider for personalized advice and to understand the full spectrum of benefits and risks associated with Rituxem therapy.
मात्रा
Active Pharmaceutical Ingredient
Uses
• Rituxem 100 mg injection is primarily used in the treatment of non-Hodgkin lymphoma (NHL). This type of cancer affects the lymphatic system, and Rituxem helps target and destroy malignant B cells. By doing so, it can significantly reduce tumor size and improve overall patient outcomes. Its effectiveness makes it a key component in the management of NHL.
• Another important use of Rituxem 100 mg injection is in the treatment of rheumatoid arthritis. This condition is characterized by chronic inflammation of the joints, leading to pain and disability. Rituxem works by depleting specific immune cells that contribute to the inflammatory process. Patients often experience reduced symptoms and improved joint function with this treatment.
• Rituxem 100 mg injection is also indicated for chronic lymphocytic leukaemia (CLL), a type of blood cancer. CLL involves the accumulation of abnormal lymphocytes, which can disrupt normal blood cell production. The administration of Rituxem targets these cancerous cells, helping to control the disease and enhance the patient's quality of life. This makes it a valuable option in CLL management.
• Additionally, Rituxem 100 mg injection is utilized in treating granulomatosis with polyangiitis and microscopic polyangiitis. These conditions are forms of vasculitis that cause inflammation of blood vessels, leading to various symptoms. Rituxem assists in reducing this inflammation by targeting specific immune responses. This can lead to remission and improved patient health outcomes in affected individuals.
Benefits
Non-Hodgkin lymphoma (NHL): Non-Hodgkin's lymphoma is a form of cancer that affects the white blood cells in the body. These cells are responsible for preventing infections. Rituxem 100 mg Injection has been demonstrated to reduce the immune response and relieve pain and inflammation. It also can kill cancer cells and prevent their further growth. To prevent the spread of infection, it is advisable to avoid crowds and to wash your hands frequently. It is recommended that patients consume an adequate quantity of fluids unless otherwise advised by their physician.
Rheumatoid arthritis: Rituxem 100 mg is an immunosuppressant that is used to treat rheumatoid arthritis. It is administered in a dose and frequency that is tailored to the patient's condition. This is determined by the physician. It is crucial to adhere to the physician's instructions and to promptly report any adverse effects, including fever, chills, or other symptoms, to the physician.
Blood cancer (chronic lymphocytic leukemia): Leukemia, also known as blood cancer, is a malignant neoplasm of the hematopoietic tissues that impairs the body's ability to combat infection. Rituxem Injection is a chemotherapeutic agent that kills or inhibits the proliferation of malignant cells and is effective in the treatment of leukemia. However, it is important to discuss the potential side effects and benefits of this medication with a qualified healthcare professional. It is also essential to inform your doctor of any adverse effects that may arise during treatment.
Granulomatosis with polyangiitis: Granulomatosis with polyangiitis (GPA) is a condition that causes inflammation of the blood vessels of the ears, nose, throat, lungs, and kidneys. In this condition, the blood flow to these areas may be reduced, which can lead to their damage. Rituxem Vial is an effective treatment that helps reduce inflammation, pain, and swelling and prevents further damage. This improves the quality of life of those affected by GPA.
Microscopic polyangiitis: Microscopic polyangiitis is an autoimmune disease that affects the small blood vessels and may be caused by an imbalance in the immune system. Rituxem 100 mg Injection reduces the immune response and improves inflammation. This helps to heal the condition and to alleviate discomfort.
Side Effects
Anti-cancer Injection Rituxem can cause various adverse effects that can differ from one person to another. Some of the adverse effects of the drug are listed below.
Most Common Side Effects
• Low Immunity
• Nausea
• Tinnitus
• Muscle Pain and Stiffness
• Face Swelling
• Low Blood Count of White Blood Cells and Red Blood Cells
• Increase in Glucose Levels in Blood
• Headache
Common Side Effects
• Skin Reactions
• Heart Problems
• Infections
• Allergies
How To Use
The administration of Rituxem Injection is typically conducted by a medical professional, such as a doctor or nurse, in a medical facility, such as a hospital or clinic. It is not advisable to administer the product independently, and it is important to adhere to the instructions provided by a qualified healthcare professional.
Safety Advice
• Alcohol: Caution should be exercised when drinking alcohol with Rituxem 100 mg. Please consult your doctor.
• Kidney: Anti-cancer Injection Rituxem is likely to be safe in patients with kidney disease. The limited data available suggest that dose adjustment of Vortuxi Solution for Infusion may not be necessary for these patients. Please consult your doctor.
• Breastfeeding: Rituxem 100 mg Injection is likely to be safe to use while breastfeeding, and limited human statistics support that the drug now no longer poses a good risk to the baby.
• Liver: Rituxem Vial is not recommended in patients with active liver disease or those who have had viral hepatitis. Please consult your doctor.
• Pregnancy: Rituxem 100 mg Injection may not be safe for use during pregnancy. Although there is limited human research, animal research has shown dangerous effects on the growing baby. Your doctor will weigh up the benefits and potential risks before prescribing it to you. Please consult your doctor.
• Driving: It is not known whether Rituxem 100 mg affects your ability to drive. Do not drive if you experience symptoms that affect your ability to concentrate and react.